Diwakar Davar

Also affiliated with University of Pittsburgh, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134”.

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Journal of Clinical Oncology(2022)10.1200/jco.22.01763

N/A

5.4DataRank · unranked

446 citations

Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach‐Giao Truong +31 more

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer Cell(2024)10.1016/j.ccell.2024.10.007

N/A

1.3DataRank · unranked

59 citations

Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0339

N/A

0.587DataRank · unranked

49 citations

Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd M. Bauer +13 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

The Oncologist(2025)10.1093/oncolo/oyaf362

N/A

0.307DataRank · unranked

6 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

medRxiv(2025)10.1101/2025.07.19.25331848

N/A

0.279DataRank · unranked

5 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-1129

N/A

0DataRank · unranked

37 citations

Hassane M. Zarour, Diwakar Davar

The role of systemic therapy in melanoma brain metastases: a narrative review

Chinese Clinical Oncology(2022)10.21037/cco-22-1

N/A

0DataRank · unranked

4 citations

Diwakar Davar, Kainat Saleem

Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9507

N/A

0DataRank · unranked

17 citations

Julie E. Stein, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I. Khushalani +13 more

605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0605

N/A

0DataRank · unranked

4 citations

Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0592

N/A

0DataRank · unranked

2 citations

Richard D. Carvajal, Diwakar Davar, Eduardo Castañón, Paolo A. Ascierto, Emiliano Calvo +16 more

Dietary tryptophan catabolite released by intratumoral Lactobacillus reuteri facilitates αPD-L1 therapy

Research Square(2022)10.21203/rs.3.rs-1633600/v1

N/A

0DataRank · unranked

1 citations

Alex McPherson, Catherine M. Phelps, Mohit Rana, Surya Pandey, Jake Shapira +10 more

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma

Research Square(2022)10.21203/rs.3.rs-2235839/v1

N/A

0DataRank · unranked

1 citations

Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

Cell(2023)10.1016/j.cell.2023.03.011

N/A

0DataRank · unranked

679 citations

Alex McPherson, Catherine M. Phelps, Surya Prakash Pandey, Colin R. Laughlin, Jake H. Shapira +20 more

Melanoma and microbiota: Current understanding and future directions

Cancer Cell(2023)10.1016/j.ccell.2023.12.003

N/A

0DataRank · unranked

82 citations

Tanisha Jackson, Laura Mählmann, Christina K. Baumgartner, Martin J. Blaser, Allyson L. Byrd +26 more

Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007567

N/A

0DataRank · unranked

17 citations

Sarah Newman, Aofei Li, Marion Joy, Maureen A. Lyons, Mary P Pham +11 more

Targeting GITR in cancer immunotherapy - there is no perfect knowledge

Oncotarget(2023)10.18632/oncotarget.28461

N/A

0DataRank · unranked

23 citations

Roberta Zappasodi, Diwakar Davar

Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients

Melanoma Research(2023)10.1097/cmr.0000000000000871

N/A

0DataRank · unranked

5 citations

Maria G. Pazan Avellan, Drew E. Hurd, Marc Schwartz, Howard M. Dubner, Corey A. Hewitt +6 more

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

Frontiers in Immunology(2023)10.3389/fimmu.2023.1171978

N/A

0DataRank · unranked

10 citations

Hassan Abushukair, Aofei Li, Andrew Knight, Ayah Nedal Al Bzour, Ian MacFawn +16 more

Tumor cell p38 inhibition to overcome immunotherapy resistance

Research Square(2023)10.21203/rs.3.rs-3183496/v1

N/A

0DataRank · unranked

5 citations

Rebekah Dadey, Ryan C. Augustin, Sarah Newman, Krishna B. Singh, Rose Doerfler +26 more

Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy

Scientific Reports(2024)10.1038/s41598-024-76583-8

N/A

0DataRank · unranked

4 citations

Lauren C. Gattie, Mohamad El Shami, Jeffrey I. Traylor, Diwakar Davar, Yana G. Najjar +4 more

Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.18.576318

N/A

0DataRank · unranked

4 citations

Lauren C. Gattie, Jeffrey I. Traylor, Diwakar Davar, Yana G. Najjar, Timothy E. Richardson +3 more

Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy

Cell(2025)10.1016/j.cell.2025.06.018

N/A

0DataRank · unranked

64 citations

Nathaniel Willis, Tingting Duan, Amanda Lee, Yue Zhang, K.J. Dhanaraj +32 more

Therapeutic potential of targeting LAG-3 in cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011652

N/A

0DataRank · unranked

13 citations

Ana. C. Anderson, Iván Díaz-Padilla, Diwakar Davar

Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0247

N/A

0DataRank · unranked

13 citations

Madison Nguyen, Drew N. Wilfahrt, Zakaria Larbi Dahmani, Ansen B.P. Burr, Bingxian Xie +15 more

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009568

N/A

0DataRank · unranked

7 citations

Zane Gray, Rebekah Dadey, Şerafettin Zenkin, Nasim Batavani, Sarah Newman +19 more

Zinc availability in the tumor microenvironment dictates anti-PD1 response in CDKN2A Low tumors via increased macrophage phagocytosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.08.637227

N/A

0DataRank · unranked

3 citations

Aidan R. Cole, Jeff Danielson, Jimmy P. Xu, Drew E. Hurd, Akash Kishore +33 more

Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma

medRxiv(2025)10.1101/2025.11.04.25339499

N/A

0DataRank · unranked

2 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +16 more

Mitochondrial Imaging Detects Early Cardiac Responses to Cancer Immunotherapy

medRxiv(2025)10.1101/2025.10.13.25337690

N/A

0DataRank · unranked

0 citations

Uttam Shrestha, Millie Das, Minal Vasanawala, Deepti Behl, Diwakar Davar +17 more

Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma

medRxiv(2025)10.1101/2025.10.26.25338837

N/A

0DataRank · unranked

0 citations

Jatin Singh, Drew E. Hurd, Tong Yu, Xin Meng, Madison Nguyen +9 more

1340 Lead-in therapy targeting PD1 and/or LAG3 distinguishes differential impacts upon the immune response in first-line treatment of metastatic melanoma

(2025)10.1136/jitc-2025-sitc2025.1340

N/A

0DataRank · unranked

0 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +15 more

IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0575

N/A

0DataRank · unranked

146 citations

Mignane Ka, Ornella Pagliano, Carmine Menna, Quanquan Ding, Richelle DeBlasio +11 more

Image Biomarkers for Predicting Immunotherapy Response in Advanced Melanoma 9065

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.2519

N/A

0DataRank · unranked

0 citations

Jatin Singh, Tong Yu, Xin Meng, Drew E. Hurd, Madison Nguyen +6 more

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.36_suppl.356154

N/A

0DataRank · unranked

111 citations

Sandra J. Lee, Bartosz Chmielowski, Antoni Ribas, Ahmad A. Tarhini, Thach‐Giao Truong +9 more

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1

Nature Medicine(2022)10.1038/s41591-022-01698-2

N/A

0DataRank · unranked

445 citations

Diwakar Davar, Richard R. Rodrigues, Jonathan H. Badger, Jennifer R. Fang, Alicia M. Cole +26 more

Tim-3 mediates T cell trogocytosis to limit antitumor immunity

Journal of Clinical Investigation(2022)10.1172/jci152864

N/A

0DataRank · unranked

69 citations

Robert M. Morrison, Joë-Marc Chauvin, Hridesh Banerjee, Diwakar Davar, Quanquan Ding +28 more

Predicting cancer immunotherapy response from gut microbiomes using machine learning models

Oncotarget(2022)10.18632/oncotarget.28252

N/A

0DataRank · unranked

43 citations

Jay‐Hyun Jo, Zhiwei Zhang, Margaret A. MacGibeny, Jungmin Han, Diana M. Proctor +13 more